Clinical Trial Update: Risk Factors and Long-term Impact of ICIs

View source ↗

Summary

This clinical trial update reports on ongoing research into risk factors and the long-term effects of immune checkpoint inhibitors in cancer patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Snippet

Sponsor: First Affiliated Hospital Xi'an Jiaotong University | Conditions: Malignant Neoplasm | Status: ACTIVE_NOT_RECRUITING